| Stacy Mai Pham, DDS | |
|
4000 Tyler St, Riverside, CA 92503 | |
| (951) 687-4155 | |
| (951) 687-7448 |
| Full Name | Stacy Mai Pham |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 4000 Tyler St, Riverside, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063420255 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 39461 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stacy Mai Pham, DDS 4000 Tyler St, Riverside, CA 92503 Ph: (951) 687-4155 | Stacy Mai Pham, DDS 4000 Tyler St, Riverside, CA 92503 Ph: (951) 687-4155 |
News Archive
Today, Medicaid Health Plans of America released a policy statement and white paper highlighting the common ground between Medicaid health plans and the patient-centered medical home model. According to MHPA, the capabilities of Medicaid plans are closely aligned with the principles of PCMHs and therefore plans should be included in states' PCMH implementation strategies. MHPA's Policy Statement notes that collaboration between states, medical home providers and health plans is essential for coordinating complex inpatient and outpatient needs of Medicaid beneficiaries.
Inovio Pharmaceuticals, Inc. announced today that its SynCon universal H1N1 influenza vaccine generated protective antibody levels comparable to a current FDA-approved seasonal influenza vaccine against a currently circulating influenza strain.
Valeant Pharmaceuticals International, Inc. today announced that it has withdrawn its offer to acquire ISTA Pharmaceuticals Inc. for $7.50 per share in cash.
BioVentrix, a pioneer of technologies and procedures for the less-invasive treatment of heart failure (HF), today announced the successful first-use of its Revivent™ Myocardial Anchoring System, via Less Invasive Ventricular Enhancement™ or the LIVE™ procedure in Germany.
The U.S. Food and Drug Administration today approved Cometriq (cabozantinib) to treat medullary thyroid cancer that has spread to other parts of the body (metastasized).
› Verified 3 days ago
Dr. Kyungsin Park, DDS Dentist Medicare: Medicare Enrolled Practice Location: 285 E Alessandro Blvd, Ste 7d, Riverside, CA 92508 Phone: 951-780-9800 Fax: 951-780-3267 | |
Han Som Lee, Dentist Medicare: Not Enrolled in Medicare Practice Location: 3457 Arlington Ave Ste 109, Riverside, CA 92506 Phone: 951-742-5208 | |
Dr. Vivian Okhee Kwon, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2955 Van Buren Blvd, Ste H4, Riverside, CA 92503 Phone: 951-689-8544 Fax: 951-689-2465 | |
Dr. Osbalda Dominga Reina, DDS Dentist Medicare: Medicare Enrolled Practice Location: 4959 Arlington Ave Ste H, Riverside, CA 92504 Phone: 951-299-7101 Fax: 951-299-7101 | |
Dr. Armound Mahmoudi, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 10168 Indiana Ave, Riverside, CA 92503 Phone: 951-352-9747 Fax: 951-352-2316 | |
Liviu Florian Eftimie, D.D.S, M.S., D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 3763 Tibbetts St, Riverside, CA 92506 Phone: 951-799-4911 Fax: 951-778-0799 | |
Manuel Humberto Guevara, DDS,MS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3679 Arlington Ave, Riverside, CA 92506 Phone: 951-683-1811 Fax: 951-782-0649 |